High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders
Fatty Acid Oxidation and Body Weight Regulation in Long-chain Fatty Acid Oxidation Disorders.
Sponsor: Oregon Health and Science University
This PHASE1/PHASE2 trial investigates Carnitine Palmitoyltransferase 2 Deficiency and Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency and is currently completed. Oregon Health and Science University leads this study, which shows 8 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE1_PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE1_PHASE2
▶ Show 3 earlier versions
-
May 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — May 2020 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
First recorded
Jan 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oregon Health and Science University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.